House bill authorises federal government to negotiate Part D prices

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.585, 2009-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

US government passes bill requiring `reasonable' drug prices

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 269, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

THE ADVANTAGES OF AWARDING THE FEDERAL GOVERNMENT NEGOTIATING POWER OVER THE PRICES OF PRESCRIPTION DRUGS

By  

Journal Of Policy Analysis And Management, Vol. 35, Iss. 4, 2016-09 ,pp. : 964-970

John Wiley & Sons Inc

Access to resources Recommend Favorite

UK health reform bill approved by House of Lords

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 650, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

US House passes Medicare drug benefit bill

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 272, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Substantial reductions in drug prices have been agreed to by Switzerland's Federal Health Office and the pharmaceutical industry for 2006

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 487, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite